|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q86552204
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000105.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q86552204
|
|
024
|
|
|
‡a
0000-0003-3126-2946
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q86552204
|
|
100
|
0 |
|
‡a
Henrique Pott-Junior
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Henrique Pott-Junior
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy
|
|
670
|
|
|
‡a
Author's Association of seasonality and serum albumin concentration with vitamin D deficiency in subjects with chronic hepatitis C infection living in a sunny country
|
|
670
|
|
|
‡a
Author's Comorbidities predict 30-day hospital mortality of older adults with COVID-19
|
|
670
|
|
|
‡a
Author's DRESS Syndrome due to Nevirapine Treated with Methylprednisolone
|
|
670
|
|
|
‡a
Author's Effects of a foot-ankle strengthening programme on clinical aspects and gait biomechanics in people with knee osteoarthritis: protocol for a randomised controlled trial
|
|
670
|
|
|
‡a
Author's Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
|
|
670
|
|
|
‡a
Author's Is the angular onset of pain during arm elevation associated to functioning in individuals with rotator cuff related shoulder pain?
|
|
670
|
|
|
‡a
Author's Mother-to-child transmission of hepatitis C virus
|
|
670
|
|
|
‡a
Author's Prevalence of IFNL3 gene polymorphism among blood donors and its relation to genomic profile of ancestry in Brazil.
|
|
670
|
|
|
‡a
Author's Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults
|
|
670
|
|
|
‡a
Author's Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil.
|
|
670
|
|
|
‡a
Author's Sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks in noncirrhotic subjects chronically infected with hepatitis C virus genotype 1: a randomized clinical trial
|
|
670
|
|
|
‡a
Author's Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
|
|
670
|
|
|
‡a
Author's Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters
|
|
909
|
|
|
‡a
(orcid) 0000000331262946
‡9
1
|
|
919
|
|
|
‡a
seroprevalenceofhepatitisevirusinchronichepatitis100inbrazil
‡A
Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil.
‡9
1
|
|
919
|
|
|
‡a
randomizedclinicaltrialoffamcicloviroracyclovirforthetreatmentofherpeszosterinadults
‡A
Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults
‡9
1
|
|
919
|
|
|
‡a
prevalenceofifnl3genepolymorphismamongblooddonorsanditsrelationtogenomicprofileofancestryinbrazil
‡A
Prevalence of IFNL3 gene polymorphism among blood donors and its relation to genomic profile of ancestry in Brazil.
‡9
1
|
|
919
|
|
|
‡a
mothertochildtransmissionofhepatitis100virus
‡A
Mother-to-child transmission of hepatitis C virus
‡9
1
|
|
919
|
|
|
‡a
istheangularonsetofpainduringarmelevationassociatedtofunctioninginindividualswithrotatorcuffrelatedshoulderpain
‡A
Is the angular onset of pain during arm elevation associated to functioning in individuals with rotator cuff related shoulder pain?
‡9
1
|
|
919
|
|
|
‡a
efficacyandsafetyofafixeddosecombinationofnimesulidepantoprazolecomparedtonaproxenesomeprazoleforpainreliefinpatientswithosteoarticulardiseasesanddyspepticsymptoms
‡A
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
‡9
1
|
|
919
|
|
|
‡a
effectsofafootanklestrengtheningprogrammeonclinicalaspectsandgaitbiomechanicsinpeoplewithkneeosteoarthritisprotocolforarandomisedcontrolledtrial
‡A
Effects of a foot-ankle strengthening programme on clinical aspects and gait biomechanics in people with knee osteoarthritis: protocol for a randomised controlled trial
‡9
1
|
|
919
|
|
|
‡a
dresssyndromeduetonevirapinetreatedwithmethylprednisolone
‡A
DRESS Syndrome due to Nevirapine Treated with Methylprednisolone
‡9
1
|
|
919
|
|
|
‡a
comorbiditiespredict30dayhospitalmortalityofolderadultswithcovid19
‡A
Comorbidities predict 30-day hospital mortality of older adults with COVID-19
‡9
1
|
|
919
|
|
|
‡a
associationofseasonalityandserumalbuminconcentrationwithvitamin500deficiencyinsubjectswithchronichepatitis100infectionlivinginasunnycountry
‡A
Association of seasonality and serum albumin concentration with vitamin D deficiency in subjects with chronic hepatitis C infection living in a sunny country
‡9
1
|
|
919
|
|
|
‡a
randomizedcontrolledtrialtoassesssafetytolerabilityandantepartumviralloadwithincreasedlopinavirritonavirdosageinpregnancy
‡A
A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy
‡9
1
|
|
919
|
|
|
‡a
vitamin500deficiencypredicts30dayhospitalmortalityofadultswithcovid19
‡A
Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
‡9
1
|
|
919
|
|
|
‡a
vitamin500deficientolderadultsaremorepronetohavemetabolicsyndromebutnottoagreaternumberofmetabolicsyndromeparameters
‡A
Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters
‡9
1
|
|
919
|
|
|
‡a
sofosbuvirincombinationwithdaclatasvirorsimeprevirfor12weeksinnoncirrhoticsubjectschronicallyinfectedwithhepatitis100virusgenotype1arandomizedclinicaltrial
‡A
Sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks in noncirrhotic subjects chronically infected with hepatitis C virus genotype 1: a randomized clinical trial
‡9
1
|
|
996
|
|
|
‡2
LC|n 87916587
|
|
996
|
|
|
‡2
ISNI|0000000066874545
|
|
996
|
|
|
‡2
ISNI|0000000416495247
|
|
996
|
|
|
‡2
ISNI|0000000037430611
|
|
996
|
|
|
‡2
BLBNB|000173857
|
|
996
|
|
|
‡2
ISNI|0000000068400730
|
|
996
|
|
|
‡2
BLBNB|000276591
|
|
996
|
|
|
‡2
DNB|1057590150
|
|
996
|
|
|
‡2
LC|no 00013983
|
|
996
|
|
|
‡2
BNCHL|10000000000000000215403
|
|
996
|
|
|
‡2
BLBNB|000553676
|
|
996
|
|
|
‡2
PTBNP|1790073
|
|
996
|
|
|
‡2
PTBNP|209113
|
|
996
|
|
|
‡2
DNB|1037188578
|
|
996
|
|
|
‡2
NTA|142794503
|
|
996
|
|
|
‡2
ISNI|0000000042903655
|
|
996
|
|
|
‡2
DNB|131903268
|
|
996
|
|
|
‡2
PTBNP|144033
|
|
996
|
|
|
‡2
ISNI|0000000428313041
|
|
996
|
|
|
‡2
PTBNP|49466
|
|
996
|
|
|
‡2
SUDOC|14836750X
|
|
996
|
|
|
‡2
LC|nb2017022250
|
|
996
|
|
|
‡2
PLWABN|9810652736005606
|
|
996
|
|
|
‡2
LC|no 00019334
|
|
996
|
|
|
‡2
PTBNP|1495426
|
|
996
|
|
|
‡2
BLBNB|000741772
|
|
996
|
|
|
‡2
PTBNP|211129
|
|
996
|
|
|
‡2
ISNI|0000000072892344
|
|
996
|
|
|
‡2
PTBNP|186537
|
|
996
|
|
|
‡2
PLWABN|9812734709505606
|
|
996
|
|
|
‡2
ISNI|0000000078314780
|
|
996
|
|
|
‡2
BLBNB|000365435
|
|
996
|
|
|
‡2
PTBNP|156982
|
|
996
|
|
|
‡2
ISNI|0000000109183147
|
|
996
|
|
|
‡2
ISNI|0000000067450322
|
|
996
|
|
|
‡2
DNB|1147900264
|
|
996
|
|
|
‡2
SUDOC|273444174
|
|
996
|
|
|
‡2
ISNI|0000000070825260
|
|
996
|
|
|
‡2
PTBNP|83080
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
